This trial is evaluating whether Risk score based intervention will improve 1 primary outcome and 1 secondary outcome in patients with Iatrogenic Disease. Measurement will happen over the course of 30 days after hospital discharge.
This trial requires 800 total participants across 2 different treatment groups
This trial involves 2 different treatments. Risk Score Based Intervention is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"The present findings are inconsistent with the hypothesis of a causal relationship between alcohol and risk-taking behaviors and with the assumption that changing risk-taking attitudes will lead to lower levels of drinking. In line with other studies, the present findings suggest that changing risk-taking attitudes towards drinking may not be the most efficacious approach to reducing alcohol-related harm." - Anonymous Online Contributor
"The prevalence of many preventive health actions varied by type of behavioral goal of risk reduction. Interventions aiming to increase uptake and maintenance of a lifestyle change may be particularly effective during midlife or as a means of reducing the risk of adverse cardiac events in women." - Anonymous Online Contributor
"The best way to assess personal risk for a disease is through comprehensive medical record review, consultation with a physician, and use of validated questionnaires." - Anonymous Online Contributor
"Most individuals who qualify for sex-specific HIV testing are not aware of their risk of contracting the virus, and are not aware of the potential benefits of sex-specific testing. Almost half of the MSM did not seek voluntary risk reduction prior to their HIV testing, and almost one third of them were unaware of the availability of pre-testning HIV prevention and risk reduction services. There are significant benefits of testing, particularly for those MSM who intend to seek additional testing in the future. Those who were not aware of available services, and who were unaware of their risk of infection, can benefit from educational campaigns to better inform them of the importance of HIV testing and risk reduction." - Anonymous Online Contributor
"Risk reduction has its own signs and symptoms when a new product is introduced for use by the public. There are also important and predictable signs and symptoms of risk reduction. In other words, risk reduction is not just cosmetic." - Anonymous Online Contributor
"The reduction of heart disease risk in the general population is still one of the major goals for health care policy in developing countries. Data from a recent study presented here show that improving diet may offer an important alternative (or additional resource) in reducing the burden of CHD in developed countries, especially among high-risk subjects." - Anonymous Online Contributor
"Given the rarity and heterogeneity of risk alleles across individuals, and the rarity and heterogeneity of risk gene transmission, we argue that genetic predisposition as a whole is primarily a complex polygenic risk, not a simple sum of single deleterious mutations." - Anonymous Online Contributor
"It is recommended that patients with risk factors for MS consider clinical trials of anti-inflammatory agents as a first step in risk reduction before initiating treatment." - Anonymous Online Contributor
"Results from a recent clinical trial is interesting because it shows that in this low-risk population, a low-dosage intervention can potentially prevent the occurrence of cardiovascular disease. The potential impact of a more effective interventions is to be investigated in future studies." - Anonymous Online Contributor
"Side effects of interventions are highly variable and often different across trials. A key aim for future research is to develop methods to inform more realistic sample sizes, and also to identify which interventions can be more effective than others." - Anonymous Online Contributor
"There are no additional RCTs for people with CVD using risk scores to identify ischemic heart disease. Risk scores are also very few in number and are mostly used for prediction of future cardiovascular events, although this is an important use of risk scores. There is good evidence of risk scores being used for secondary prevention, and with further large clinical trials, their use should expand. However, the evidence for primary interventions is weaker, although further large trials are needed." - Anonymous Online Contributor
"Patients with low risk of future events showed a better evolution and reduced rate of complications after hospital discharge, suggesting that intervention is needed on those patients." - Anonymous Online Contributor